Many treatments that are now available to patients around the world were pioneered at our National Cancer Institute-designated research center: Masonic Cancer Center, University of Minnesota. That includes blood and marrow transplant, which is currently the only cure for MDS patients. The world’s first successful BMT was completed here in 1968, and our providers have treated thousands of patients with BMT since.

Our care team creates individualized treatment plans for MDS patients by evaluating not only the type and severity of the disease, but also the patient’s overall health and goals for treatment. For those patients who are not good candidates for a BMT, numerous chemotherapy treatment choices exist.

We continue to perform leading-edge research in collaboration with scientists at the Masonic Cancer Center with the goal of improving treatments while limiting side effects. This research often benefits patients who have failed standard therapies.

Information for providers looking to refer patients may be found here.